Global Bio-chem Technology Group Company Limited
Simbols: 0809.HK
HKSE
0.102
HKDTirgus cena šodien
0.2024
P/E koeficients
0.0037
PEG koeficients
908.56M
MRK Cap
- 0.00%
DIV ienesīgums
Global Bio-chem Technology Group Company Limited (0809-HK) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 88.4 | 41.8 | 21.8 | ||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 227.3 | 53.9 | 87.3 | ||||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 395.9 | 279.3 | 443.1 | ||||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 148.3 | 216.7 | 81.4 | ||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 336.9 | 149.6 | 45.4 | ||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 969.5 | 687.6 | 592.2 | ||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 4220.2 | 5158.4 | 5886.5 | ||||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 2 | 3.8 | 3.8 | ||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 2 | 3.8 | 3.8 | ||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 17.3 | 0.2 | 0.2 | ||||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | -0.2 | -0.2 | ||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0.2 | 0.2 | ||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 4239.6 | 5162.3 | 5890.5 | ||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 5209.1 | 5849.9 | 6482.7 | ||||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 904.2 | 1201.5 | 1172.2 | ||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 4637.7 | 8152.9 | 7503.2 | ||||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 103.5 | 331.4 | 319.7 | ||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 811.8 | 0.3 | 941.1 | ||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 31.3 | 100.8 | 115.2 | ||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 2697.7 | 4032.4 | 3268.1 | ||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 850.4 | 130.9 | 1147.9 | ||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0.3 | 2.2 | 4.1 | ||||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 9246 | 13636.9 | 13183.5 | ||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 11279 | 10257.7 | ||||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 890.7 | 890.7 | 890.7 | ||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -9832.2 | -15203.9 | -13760.8 | ||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 2055.2 | 3924.9 | 3503.1 | ||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2849.3 | -8429.7 | -7408.4 | ||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | -4036.9 | -7539 | -6517.7 | ||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 5209.1 | 5849.9 | 6482.7 | ||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | -248.1 | -183.1 | ||||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | -4036.9 | -7787.1 | -6700.8 | ||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||||||||
Total Investments | 0 | 17.3 | 0.2 | 0.2 | ||||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 5449.5 | 8153.2 | 8444.3 | ||||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 5361.2 | 8111.5 | 8422.5 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -1573.8 | -409.5 | -2410.9 | |||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 330.5 | 402.5 | 456.9 | |||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 413.9 | 38.1 | 566.3 | |||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | 47 | 21.3 | 119.2 | |||||||||||||||||||||||
cash-flows.row.inventory | 0 | -142.1 | 36.1 | 243.4 | |||||||||||||||||||||||
cash-flows.row.account-payables | 0 | 114.1 | -216.3 | -286 | |||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 394.9 | 197 | 489.7 | |||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 741.4 | -506.4 | 1361.5 | |||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -6.2 | -25.8 | -16.8 | |||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 5.8 | 418.4 | 0 | |||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 136.9 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -0.4 | 392.6 | 120.1 | |||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -68.9 | -404.3 | -365 | |||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 132.7 | |||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 178.7 | 355.6 | 206.4 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 109.8 | -48.7 | -25.9 | |||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -1.4 | -0.2 | 5.8 | |||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 20 | -131.5 | 73.8 | |||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 41.8 | 21.8 | 153.3 | |||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 21.8 | 153.3 | 79.5 | |||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -88 | -475.2 | -26.2 | |||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -6.2 | -25.8 | -16.8 | |||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -94.2 | -501 | -43 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1373.9 | 372.3 | 746.6 | ||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1330.3 | 337.7 | 698.2 | ||||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 43.6 | 34.6 | 48.4 | ||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -237.7 | -1 | -5.3 | ||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 361.8 | 366.9 | 430.9 | ||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1692.1 | 704.5 | 1129.1 | ||||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0.3 | ||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 750.4 | 726.2 | 790.6 | ||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 4019.2 | -724.4 | 564.4 | ||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -237.7 | -1 | -5.3 | ||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 4019.2 | -724.4 | 564.4 | ||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 750.4 | 726.2 | 790.6 | ||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 241.8 | 330.5 | 402.5 | ||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | -318.2 | -849.4 | -973.8 | ||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 3701 | -1573.8 | -409.5 | ||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -42.1 | -54.2 | 25.9 | ||||||||||||||||||||||||
income-statement-row.row.net-income | 0 | 4224.6 | -1519.6 | -435.4 |
Biežāk uzdotie jautājumi
Kas ir Global Bio-chem Technology Group Company Limited (0809.HK) kopējie aktīvi?
Global Bio-chem Technology Group Company Limited (0809.HK) kopējie aktīvi ir 5209096000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir N/A.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.032.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir -0.017.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 3.075.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir -0.238.
Kāda ir Global Bio-chem Technology Group Company Limited (0809.HK) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir 4224593000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 5449538000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 361805000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 0.000.